Study to Evaluate Multiple Doses of Fluconazole, a CYP3A4 and CYP2C9 Inhibitor, on the Pharmacokinetics of CTP-543 in Healthy Subjects
Condition: Health Volunteers Interventions: Drug: CTP-543; Drug: Fluconazole Sponsor: Concert Pharmaceuticals Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 28, 2022 Category: Research Source Type: clinical trials